Skip to main content
. 2024 Jan 18;20:6. doi: 10.1186/s13005-024-00407-3

Table 5.

Hematologic indices of systemic inflammation according to different disability level groups

Low (n = 77) High (n = 22) P-value
WBC 5.83 (1.42) 6.02 (1.39) 0.584
WBC group (≥ 10)‡‡ 1.30% (1/77) 0.00% (0/22) 1.000
RBC 4.51 (0.37) 4.43 (0.34) 0.355
RBC group (≥ 5.40)‡‡ 6.49% (5/77) 9.09% (2/22) 0.650
Hgb†† 13.70 (12.80, 14.30) 13.60 (12.65, 14.05) 0.426
Hgb group (< 12)‡‡ 2.60% (2/77) 4.55% (1/22) 0.534
Hct 40.71 (3.11) 39.96 (2.74) 0.315
Hct group (≤ 36)‡‡ 3.90% (3/77) 9.09% (2/22) 0.307
Platelet 262.90 (47.60) 269.32 (51.68) 0.589
PLR†† 82.87 (30.38) 86.88 (32.68) 0.749
PLR group (≥ 142.76 (F), ≥ 122.73 (M))‡‡ 3.90% (3/77) 4.55% (1/22) 1.000
NLR†† 1.13 (0.76) 1.25 (0.83) 0.614
NLR group (≥ 1.662 (F), ≥ 1.634 (M))‡‡ 15.58% (12/77) 27.27% (6/22) 0.222
dNLR 1.40 (0.53) 1.47 (0.62) 0.601
LMR†† 5.10 (3.93, 6.26) 4.83 (3.84, 5.68) 0.711
LMR group (≤ 5.598 (F), ≤ 5.048 (M)) 33.77% (26/77) 31.82% (7/22) 1.000
SII†† 249.58 (171.78, 356.45) 255.39 (181.97, 399.05) 0.668
ESR (mm/h)†† 5.00 (2.00, 10.00) 9.00 (4.25, 14.75) 0.440
CRP (mg/L)†† 0.04 (0.02, 0.08) 0.05 (0.04, 0.08) 0.354
RF‡‡ 1.30% (1/76) 4.50% (1/22) 0.400
FANA 29.90% (23/77) 18.20% (4/22) 0.416
Anti-CCP‡‡ 3.90% (3/77) 0.00% (0/22) 1.000
Total protein (g/dL)†† 7.40 (7.1, 7.7) 7.30 (7.0, 7.58) 0.660

WBC: White blood cell, RBC: Red blood cell, Hgb: Hemoglobin, Hct: Hematocrit, PLR: Platelet-to-lymphocyte ratio, NLR: Neutrophil-lymphocyte ratio, dNLR: derived neutrophil-lymphocyte ratio, LMR: Lymphocyte-monocyte ratio, SII: Systemic inflammatory index, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, RF: Rheumatoid factor, FANA: Fluorescent antinuclear antibody, anti-CCP: anti-cyclic citrullinated peptide

Differences between groups were tested with independent t-test: mean (standard deviation)

††Differences between groups were tested with Mann-Whitney test: median (lower quartile, upper quartile)

Differences between groups were tested with chi-square test: number of subjects or positive palpation sites (%)

‡‡Differences between groups were tested with Fisher’s exact test: number of subjects or positive palpation sites (%)

*Significant difference, p < 0.05